covid 19 News and Research

RSS

Vaccines likely to be effective against SARS-CoV-2 D614G mutation

The emergence of the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutation D614G has raised many questions, including whether it will cause the virus to become resistant to the vaccines produced against earlier versions of the virus. A new study published in the journal npj Vaccines in October 2020 shows that this may be an unfounded fear.

11 Oct 2020

Rapid and sensitive detection of SARS-CoV-2 with functionalized magnetic nanoparticles

A recent study published on the preprint server arXiv in October 2020 shows the potential for using functionalized magnetic nanoparticles to detect the presence of the virus in a sample.

11 Oct 2020

Analysis of existing comorbidities and COVID-19 mortality

As the COVID-19 pandemic continues to spread, and research related to potential risk factors for COVID-19 mortality continues, it is becoming clear that individuals with underlying comorbidities have a greater risk of death from COVID-19. The exact contribution of different comorbidities is unclear, however. Now, a new study published in the journal PLOS ONE dissects this topic and may help to quantify the risk posed by specific conditions and offer help with the prognosis.

11 Oct 2020

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

In a study by researchers explored the possible mechanisms of the clotting disorder, focusing on the role of hypoxia-related activation of coagulation factors; cytokine storm, activation of neutrophils, and the release of neutrophil extracellular traps.

11 Oct 2020

Fetal brain models could predict neurodevelopmental outcomes of COVID-19 exposure

Researchers in the United States and Sweden have created personalized models of fetal brain microglia to investigate the effects of maternal infection on the developing brain, including infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

11 Oct 2020

New age and sex-specific model of COVID-19 transmission

Researchers at the University of Rostock in Germany have developed a model of coronavirus disease 2019 (COVID-19) transmission that considers subdivisions of age and sex to provide better insights into the impact that increased contact rates might have on the risk of infection and mortality.

11 Oct 2020

Exciting findings on CD8 T cell response in recovered COVID patients

An international team of scientists has identified novel T cell-recognized epitopes spanning different proteins of severe acute respiratory syndrome coronavirus 2 in COVID-19 recovered patients. The scientists have also revealed phenotypical characteristics of the T cell population.

11 Oct 2020

WVU receives $1.2 million to bring telehealth capabilities to rural emergency departments

Rural emergency departments often lack the medical specialists who staff larger, urban hospitals. Yet rural patients have the same conditions--and need the same prompt care--that people in cities do.

9 Oct 2020

Ottawa Public Health receiving new metric to help measure COVID-19 levels in wastewater

Ottawa Public Health is receiving new metric to help measure levels of COVID-19 in the community: wastewater.

9 Oct 2020

Study shows unique cardioprotective properties of an old drug

A drug costing less than 2 euros per dose could reduce the long term consequences of a heart attack, benefitting millions of patients. Metoprolol, a member of the beta-blocker class of drugs that has been in use for more than 40 years, has been found to have unique cardioprotective properties.

9 Oct 2020

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters.

9 Oct 2020

Antibody cocktail may offer clinical benefit in both prevention and treatment of COVID-19

In June, two studies in Science reported an antibody cocktail against SARS-CoV-2 developed from studies in humanized mice and recovering patients. The two antibody cocktail was designed to bind the virus to reduce the risk of a drug-resistant form emerging.

9 Oct 2020

Investment in PPE for health care workers saves lives, provides substantial economic return

Providing adequate personal protective equipment (PPE) for all health care workers around the world requires an initial investment of billions of dollars, but the returns on that investment could be close to 8000% in productivity gains, according to a new study published this week in the open-access journal PLOS ONE by Nicholas Risko of the Johns Hopkins University School of Medicine and colleagues.

9 Oct 2020

Exuberant activation of immune cells in severe COVID-19 resembles lupus

In severe cases of COVID-19, Emory researchers have been observing an exuberant activation of immune cells, resembling acute flares of systemic lupus erythematosus (SLE), an autoimmune disease.

9 Oct 2020

Key insights into harnessing the tools of population health to combat COVID-19

Battling the COVID-19 pandemic and preparing for the inevitable next surge requires a data-driven population health approach.

9 Oct 2020

COVID-19-related social distancing measures reduce noise exposure nearly in half

People's exposure to environmental noise dropped nearly in half during the early months of the coronavirus pandemic, according to University of Michigan researchers who analyzed data from the Apple Hearing Study.

9 Oct 2020

Over $1 million CIHR funding for six uOttawa COVID-19 mental health projects

Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).

9 Oct 2020

Stigma against D.O.s had been dissipating until Trump’s doctor took the spotlight

Dr. Katherine Pannel was initially thrilled to see President Donald Trump's physician is a doctor of osteopathic medicine.

9 Oct 2020

As Trump touts his ‘great’ COVID drugs, the pharma cash flows to Biden, not him

Pharmaceutical giants Regeneron and Gilead Sciences got the kind of publicity money can't buy this week after President Donald Trump took their experimental drugs for his coronavirus infection, left the hospital and pronounced himself fully recovered.

9 Oct 2020

Researchers receive €2.35 million to examine disease pathways of viruses

Two University College Dublin (UCD) researchers and SiriusXT, a UCD spin-out company, have been awarded a total of €2.35 million in funding for a disruptive photonics technology project, through Horizon 2020, the EU's research and innovation programme, to examine the disease pathways of viruses.

9 Oct 2020

covid 19 News and Research

Vaccines likely to be effective against SARS-CoV-2 D614G mutation

Rapid and sensitive detection of SARS-CoV-2 with functionalized magnetic nanoparticles

Analysis of existing comorbidities and COVID-19 mortality

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

Fetal brain models could predict neurodevelopmental outcomes of COVID-19 exposure

New age and sex-specific model of COVID-19 transmission

Exciting findings on CD8 T cell response in recovered COVID patients

WVU receives $1.2 million to bring telehealth capabilities to rural emergency departments

Ottawa Public Health receiving new metric to help measure COVID-19 levels in wastewater

Study shows unique cardioprotective properties of an old drug

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Antibody cocktail may offer clinical benefit in both prevention and treatment of COVID-19

Investment in PPE for health care workers saves lives, provides substantial economic return

Exuberant activation of immune cells in severe COVID-19 resembles lupus

Key insights into harnessing the tools of population health to combat COVID-19

COVID-19-related social distancing measures reduce noise exposure nearly in half

Over $1 million CIHR funding for six uOttawa COVID-19 mental health projects

Stigma against D.O.s had been dissipating until Trump’s doctor took the spotlight

As Trump touts his ‘great’ COVID drugs, the pharma cash flows to Biden, not him

Researchers receive €2.35 million to examine disease pathways of viruses

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News